Insider Trading26 Jun 2026, 04:28 pm
Alembic Pharma Closes Trading Window for Q1 FY27 Results
AI Summary
Alembic Pharmaceuticals Ltd has announced the closure of its trading window for designated persons and their immediate relatives. This closure is in accordance with SEBI (Prohibition of Insider Trading) Regulations, 2015, and the company's internal code of conduct. The trading window will be shut from July 1, 2026, until 48 hours after the declaration of the unaudited financial results for the quarter ended June 30, 2026. The specific date for the board meeting to approve these results will be communicated separately.
Key Highlights
- Trading window closed from July 1, 2026.
- Closure is for Q1 FY27 financial results announcement.
- Effective until 48 hours post-results declaration.
- Adheres to SEBI insider trading regulations.
- Board meeting date for results to be announced later.
Price Impact
More from APLLTD